Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sonoma Pharmaceuticals Inc (NASDAQ:SNOA)

5.34
Delayed Data
As of Sep 22
 -0.04 / -0.74%
Today’s Change
3.91
Today|||52-Week Range
8.25
+5.95%
Year-to-Date
No recent news for Sonoma Pharmaceuticals Inc.

Today’s Trading

Previous close5.38
Today’s open5.36
Day’s range5.24 - 5.39
Volume17,381
Average volume (3 months)20,866
Market cap$23.0M
Dividend yield--
Data as of 4:00pm ET, 09/22/2017

Growth & Valuation

Earnings growth (last year)+20.54%
Earnings growth (this year)-229.95%
Earnings growth (next 5 years)--
Revenue growth (last year)-14.98%
P/E ratioNM
Price/Sales2.36
Price/Book1.07

Competitors

 Today’s
change
Today’s
% change
PRANPrana Biotechnology ...-0.02-0.74%
CAPRCapricor Therapeutic...+0.14+7.00%
AVIRAviragen Therapeutic...+0.03+4.00%
OCRXOcera Therapeutics I...-0.05-4.10%
Data as of 3:59pm ET, 09/22/2017

Financials

Next reporting dateNovember 9, 2017
EPS forecast (this quarter)-$0.69
Annual revenue (last year)$12.8M
Annual profit (last year)-$10.4M
Net profit margin-67.59%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
James J. Schutz
Chief Operating &
Financial Officer
Robert E. Miller
Corporate headquarters
Petaluma, California

Forecasts